[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP0904454A1 - Substitutes for modified starch in paper manufacture - Google Patents

Substitutes for modified starch in paper manufacture

Info

Publication number
EP0904454A1
EP0904454A1 EP96925260A EP96925260A EP0904454A1 EP 0904454 A1 EP0904454 A1 EP 0904454A1 EP 96925260 A EP96925260 A EP 96925260A EP 96925260 A EP96925260 A EP 96925260A EP 0904454 A1 EP0904454 A1 EP 0904454A1
Authority
EP
European Patent Office
Prior art keywords
glucan
produced
starch
paper
maize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96925260A
Other languages
German (de)
French (fr)
Inventor
Scott E. Nichols
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pioneer Hi Bred International Inc
Original Assignee
Pioneer Hi Bred International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pioneer Hi Bred International Inc filed Critical Pioneer Hi Bred International Inc
Publication of EP0904454A1 publication Critical patent/EP0904454A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/18Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H17/00Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
    • D21H17/005Microorganisms or enzymes
    • DTEXTILES; PAPER
    • D21PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21HPULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H19/00Coated paper; Coating material

Definitions

  • the present invention involves the field of paper manufacture. Specifically, the present invention provides sources alternative to modified starch in paper manufacture.
  • the second phase in paper manufacturing involving starch is the "sizing step".
  • the paper goes through a sizing press where a starch slurry is applied to the sheet.
  • the sheet again goes through a series of foils and rolls. It is dried on rollers and can be taken off the press as a finished product.
  • the third step involves coating the paper with a mixture of starch and a thermoplastic molecule. On certain lines, this occurs after the sizing step.
  • the nascent roll can also be removed and reinstalled onto a different press for coating.
  • a typical coating device has two blades that run the width of the paper. The blades apply the coating material onto two rolling drums. The paper passes between the drums and the coating material, comprising starch and the thermoplastic moiety, comes off the drums onto the paper. After the paper leaves the drums, it goes through a number of dryers. When the paper is dry, it goes onto a "soft calendar" comprising two drums, one made of a hard density fabric and the other a heated steel drum. The paper passes between the two drums and the heated steel drum is sufficiently hot to melt thermoplastic components of the coating mix providing a hard gloss finish on the paper.
  • the cellulosic wood pulp fibers typically used in the above process, are anionic in nature.
  • a cationic starch to the "wet end" slurry acts as an adhesive by cross linking the pulp fibers through salt linkages.
  • a cross linked polymeric network is made, comprising the starch and cellulose fibers.
  • the cationic starches used in the "wet end” are tertiary or quaternary amines. These amino groups are added to the starch by wet millers .
  • sizing starches are used to impart both strength and smooth finish to the sheet after it leaves the "wet end". Such starches also prepare the sheet to receive the various coatings. In cheaper grades of paper and in fiberboard manufacture, sizing starches are used simply as unmodified corn starch. For high grades of paper, chemically-modified starches are used. This is important for the application of a smooth, uniform high quality surface to the paper.
  • the starch most often used for sizing applications is a starch having a covalently attached neutral adduct, for instance hydroxyethyl starch. This is prepared by the reaction of ethylene oxide with starch after it is isolated at the wet milling plant.
  • the function of the hydroxyethyl (or similar) adduct is independent of its chemical nature; rather, it serves to provide steric hindrance, inhibiting the formation of high ordered structures. This steric hindrance is critical to decrease retrogradation.
  • the periodic protuberance afforded by the adduct disrupts the formation of higher ordered structures that leads to retrogradation.
  • Hydroxethylated starch also forms higher ordered structures as the temperature decreases or the concentration increases.
  • the formation of the higher ordered structures on the surface of the paper is required. After application to the sheet the starch reforms some of these higher ordered structures and creates a uniform surface that imparts structural strength and facilitates the acceptance of inks and dyes.
  • the higher ordered structures should not form in the slurry nor on the application device because this necessitates shutting down the production line to clear off retrograded starch.
  • the function of the hydroxyethyl group is to lower the temperature and/or raise the concentration of starch at which retrogradation occurs.
  • a decrease in the tendency to retrograde would allow for a higher carbohydrate content in the slurry.
  • the mixture applied to the paper sheet in the coating process contains hydroxethylated starch and thermoplastic molecules.
  • the most prevalent thermoplastic molecules used are latexes, such as styrene butadiene.
  • the function of the hydroxethyl starch is as indicated above.
  • the function of the thermoplastic molecule is to form a high gloss finish on the paper. This causes an increased ability to take inks and dyes and improves the resolution, in general, on the printed sheet.
  • thermoplastic molecules currently used in the coating step during paper manufacture.
  • the present invention provides glucans which can be used as substitutes for modified starch and latexes in paper manufacture.
  • the present glucans are produced by the glucosyltransferase C ("GTF C") enzyme of the species Streptococcus mutans, and are functionally similar to the modified starch currently used in paper manufacture.
  • GTF C glucosyltransferase C
  • the present glucans also exhibit similar physical properties to thermoplastic molecules currently used in the coating step during paper manufacture.
  • the present invention also provides methods of making paper utilizing the present glucans, input materials that are produced biologically.
  • the present methods are more cost-effective and environmentally-friendly than current methods, which require input materials that produce chemical effluents.
  • glucose means a glucose polymer having linkages that are Q C(1—»3) , oc(l-»6) and branching oc(l—»3,6) .
  • amphostyloplast means starch accumulating organelle in plant storage tissue.
  • Streptococcus mutans is a species that is endogenous to the oral cavity and colonizes tooth enamel. See e.g. Kuramitsu, et al., "Characterization of Extracellular Glucosyl Transferase Activity of Streptococcus-mutans, " Infect. Immun. ; Vol. 12(4); pp. 738-749; (1975); and Yamashita, et al., "Role of the Streptococcus-Mutans-gtf Genes in Caries Induction in the Specific-Pathogen-Free Rat Model," Infect. Immun.; Vol.
  • Streptococcus mutans species secrete the glucosyltransferase C ("GTF C") enzyme which utilizes dietary sucrose to make a variety of extracellular glucans.
  • GTF C glucosyltransferase C
  • the structure of the glucans produced by the GTF C enzyme is quite heterogeneous with respect to the proportions of ⁇ x(l—>3), oc(l—>6) and oc(l—>3, 6) branches present m any given glucan. Transformation of genes which encode naturally occurring GTF C into plants, such as maize, provides amyloplasts and vacuoles with novel compositions.
  • GTF C enzyme activity incorporated into the amyloplast and/or vacuole leads to the accumulation of starch and glucan in the same amyloplast and/or vacuole.
  • Retrogradation occurs as portions of starch molecules interact and subsequently form inter- or intra-chain helices. In a mixture of starch and glucans, the frequency of starch-starch interactions that lead to helix formation is diminished. A paste made from the mixed polymers is less prone to retrogradation as a result. This is especially true in the starch accumulation mutants envisioned as transformation targets where the relative proportion of starch is reduced.
  • Glucans produced in maize amyloplasts and/or vacuoles by the transgenic GTF C enzyme can function in paper processing without chemical modification, as required of starch.
  • the polymer solution consequently has altered rheological properties and is less prone to retrogradation compared to starch.
  • the glucans are branched and irregular and able to supplant modified starches with comparable or superior efficacy. They do not require any costly chemical modification as does starch.
  • the present glucans exhibit thermoplastic properties in addition to the above advantages.
  • the wild type of GTF C is useful m producing glucans according to the present invention.
  • the GTF C enzyme is well known. See e.g. Shimamura et al .
  • the glucans produced are particularly useful as substitutes for modified starches in the coating step of paper manufacture.
  • the present glucans are also useful as substitutes for thermoplastic molecules such as latex (e.g. styrene butadiene).
  • the subject glucans impact a high gloss finish on the paper and increase the ability of the paper to take on dyes and inks and improves the resolution in general on the printed sheet.
  • the glucans of the present invention are preferably produced in transgenic maize, potato, cassava, sweet potato, rye, barley, wheat, sorghum, oats, millet, triticale, sugarcane and rice. More preferably, the present glucans are produced in maize, potato, sugarcane, cassava, and sweet potato. Even more preferably, the present glucans are produced in maize and potato. Most preferably, the present glucans are produced in maize.
  • maize lines deficient in starch biosynthesis are transformed with GTF C genes.
  • Such lines may be naturally occurring maize mutants (i.e. sh 2 , bty, bt L ) or transgenic maize engineered so as to accumulate low amounts of starch in the endosperm when compared to wild type maize.
  • sh 2 , bty, bt L a naturally occurring maize mutants
  • transgenic maize engineered so as to accumulate low amounts of starch in the endosperm when compared to wild type maize See e.g. Muller-Rober, et al., "Inhibition of the ADP-glucose Pyrophosphorylase in Transgenic Potatoes Leads to Sugar- Storing Tubers and Influences Tuber Formation and Expression of Tuber Storage Protein Genes," The EMBO Journal; Vol. 11(4); pp. 1229-1238; (1992); and Creech, "Carbohydrate Synthesis in Maize," Advances in Agronomy; Vol. 20; pp
  • the production of the present glucans is performed according to methods of transformation that are well known in the art, and thus constitute no part of this invention.
  • the compounds of the present invention are synthesized by insertion of an expression cassette containing a synthetic gene which, when transcribed and translated, yields a GTF enzyme that produces the desired glucan.
  • Such empty expression cassettes providing appropriate regulatory sequences for plant expression of the desired sequence, are also well-known, and the nucleotide sequence for the synthetic gene, either RNA or DNA, can readily be derived from the amino acid sequence for the protein using standard texts and the references provided.
  • the above-mentioned synthetic genes preferably employ plant-preferred codons to enhance expression of the desired protein.
  • compositions of this invention and the methods of making and using them.
  • other methods known by those of ordinary skill in the art to be equivalent, can also be employed.
  • genes which code for the present enzyme can be inserted into an appropriate expression cassette and introduced into cells of a plant species.
  • an especially preferred embodiment of this method involves inserting into the genome of the plant a DNA sequence coding for a mutant or wild type in proper reading frame, together with transcription promoter and initiator sequences active in the plant. Transcription and translation of the DNA sequence under control of the regulatory sequences causes expression of the protein sequence at levels which provide an elevated amount of the protein in the tissues of the plant.
  • Synthetic DNA sequences can then be prepared which code for the appropriate sequence of amino acids of GTF C protein, and this synthetic DNA sequence can be inserted into an appropriate plant expression cassette.
  • Plant expression cassettes and vectors applicable in the present invention are well known in the art.
  • expression cassette is meant a complete set of control sequences including promoter, initiation, and termination sequences which function in a plant cell when they flank a structural gene in the proper reading frame.
  • Expression cassettes frequently and preferably contain an assortment of restriction sites suitable for cleavage and insertion of any desired structural gene. It is important that the cloned gene have a start codon m the correct reading frame for the structural sequence.
  • vector herein is meant a DNA sequence which is able to replicate and express a foreign gene in a host cell.
  • the vector has one or more restriction endonuclease recognition sites which may be cut in a predictable fashion by use of the appropriate enzyme such vectors are preferably constructed to include additional structural gene sequences imparting antibiotic or herbicide resistance, which then serve as markers to identify and separate transformed cells.
  • markers/selection agents include kanamycm, chlorosulfuron, phosphonothricm, hygromycin and methotrexate.
  • a cell in which the foreign genetic material in a vector is functionally expressed has been "transformed" by the vector and is referred to as a "transformant" .
  • a particularly preferred vector is a plasmid, by which is meant a circular double-stranded DNA molecule which is not a part of the chromosomes of the cell.
  • genomic DNA and cDNA encoding the gene of interest may be used in this invention.
  • the gene of interest may also be constructed partially from a cDNA clone and partially from a genomic clone.
  • genetic constructs are made which contain the necessary regulatory sequences to provide for efficient expression of the gene in the host cell.
  • the genetic construct will contain (a) a genetic sequence coding for the protein or trait of interest and (b) one or more regulatory sequences operably linked on either side of the structural gene of interest.
  • the regulatory sequences will be selected from the group comprising of promoters and terminators.
  • the regulatory sequences may be from autologous or heterologous sources.
  • the expression cassette comprising the structural gene for a mutant of this invention operably linked to the desired control sequences can be ligated into a suitable cloning vector.
  • plasmid or viral (bacteriophage) vectors containing replication and control sequences derived from species compatible with the host cell are used.
  • the cloning vector will typically carry a replication origin, as well as specific genes that are capable of providing phenotypic selection markers in transformed host cells. Typically, genes conferring resistance to antibiotics or selected herbicides are used. After the genetic material is introduced into the target cells, successfully transformed cells and/or colonies of cells can be isolated by selection on the basis of these markers .
  • an intermediate host cell will be used in the practice of this invention to increase the copy number of the cloning vector.
  • the vector containing the gene of interest can be isolated in significant quantities for introduction into the desired plant cells.
  • Host cells that can be used in the practice of this invention include prokaryotes, including bacterial hosts such as E. coli, S. typhimurium, and Serratia marcescens.
  • Eukaryotic hosts such as yeast or filamentous fungi may also be used in this invention. Since these hosts are also microorganisms, it will be essential to ensure that plant promoters which do not cause expression of the protein in bacteria are used in the vector.
  • the isolated cloning vector will then be introduced into the plant cell using any convenient technique, including electroporation (in protoplasts) , retroviruses, bombardment, and microinjection into cells from monocotyledonous or dicotyledonous plants in cell or tissue culture to provide transformed plant cells containing as foreign DNA at least one copy of the DNA sequence of the plant expression cassette.
  • electroporation in protoplasts
  • retroviruses retroviruses
  • bombardment and microinjection into cells from monocotyledonous or dicotyledonous plants in cell or tissue culture to provide transformed plant cells containing as foreign DNA at least one copy of the DNA sequence of the plant expression cassette.
  • protoplasts can be regenerated and cell or tissue culture can be regenerated to form whole fertile plants which carry and express the gene for a protein according to this invention.
  • a highly preferred embodiment of the present invention is a transformed maize plant, the cells of which contain as foreign DNA at least one copy of the DNA sequence of an expression cassette of the GTF C protein.
  • this invention provides a method for introducing GTF C in Agrobacterium tumefaciens- susceptible dicotyledonous plants in which the expression cassette is introduced into the cells by infecting the cells with Agrobacterium tumefaciens, a plasmid of which has been modified to include a plant expression cassette of this invention.
  • the potato plant can be transformed via Agrobacterium tumefaciens to produce the present glucans.
  • the transformation cassette comprises a patatin promoter, followed by the GTF C coding sequence and the neomycin phosphotransferase polyadenylation site/terminator. See e.g. Utsumi, et al., "Expression and Accumulation for Normal and Modified Soybean Glycinins in Potato Tubers," Plant Science; Vol. 102(2); pp. 181-188; (1994); (Limerick); incorporated herein in its entirety by reference.
  • the transgenic cassette is placed into a transformation vector.
  • BIN19 or derivatives thereof, are useful when transforming via Agrobacterium tumefaciens. See e.g. Visser, et al . , "Transformation of Homozygous Diploid Potato with an Agrobacterium-tumefaciens Binary Vector System by Adventitious Shoot Regeneration on Leaf and Stem Segments, " Plant Mol. Biol. ; Vol. 12(3); pp. 329-338; (1989); incorporated herein in its entirety by reference.
  • the promoters include any promoter whose expression is specific and limited to endosperm cells. Included are those encoding either 22 kDa zein, opaque2, gamma zein and waxy. These lead into the GTF C gene and are followed by the endogenous terminator or the heterogeneous PINII terminator.
  • the GTF C protein is directed to the maize endosperm amyloplast using a suitable transit sequence.
  • Transit sequences useful in directing the enzyme into the amyloplast for accumulation within the amyloplast include but are not limited to ribulose biphosphate carboxylase small subunit, waxy, brittle-1, and chlorophyll AB binding protein.
  • the transit sequences are juxtaposed between the promoter and the GTF C coding sequence and fused in translational reading frame with the GTF C moiety.
  • Transit sequences useful in directing the enzyme into the vacuole for accumulation within the vacuole are well known in the art. For vacuolar targeting, see e.g. Ebskamp, et al., "Accumulation of Fructose Polymers in Transgenic Tobacco," Bio/technology; Vol. 12; pp. 272-275; (1994); incorporated herein in its entirety by reference.
  • the glucans synthesized can be isolated, by standard methods, known to one skilled in the art.
  • the glucans thus obtained in the transgenic plant can be substituted for modified starches and utilized in the sizing and/or coating steps.
  • formulations useful in the coating step see e.g. Heiser, et al., "Starch Formations,” Starch and Starch Products in Paper Coating; Kearney, et al. , eds., pp. 147-162; (1990); Tappi Press; incorporated herein in its entirety by reference.
  • the present glucans are utilized in an amount of from about 4 to about 15 weight percent, more preferably from about 5 to about 12 weight percent, also preferably from about 6 to about 8 weight percent. Weight percent is defined as grams of molecule per 100 ml coating solution.
  • the present glucans are used to replace the starch and/or latex molecules completely, or a starch-glucan or a latex-glucan mixture is used in the slurry.
  • the glucan:starch ratio preferably ranges from about 10:90 to about 100:0; more preferably from about 40:60 to about 100:0; more preferably still from about 60:40 to about 100:0; most preferably about 100:0.
  • the glucan:latex ratio preferably ranges from about 10:90 to about 100:0; more preferably from about 40:60 to about 100:0; more preferably still from about 60:40 to about 100:0; most preferably about 100:0.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Paper (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

The present invention provides methods of making paper utilizing glucans, produced by the glucosyltransferase C enzyme of the species Streptococcus mutans, instead of modified starches. The present glucans are functionally similar to the hydroxethyl modified starch and are particularly useful in the coating step of paper manufacture. The present glucans also exhibit thermoplastic properties and impart gloss to the paper during the coating step.

Description

SUBSTITUTES FOR MODIFIEDSTARCH IN PAPER MANUFACTURE
Field of the Invention
The present invention involves the field of paper manufacture. Specifically, the present invention provides sources alternative to modified starch in paper manufacture.
Background of the Invention
There are three major phases in paper manufacture where starch is used as an ingredient. The first is the "wet end" where cellulose fibers are mixed with starch in a slurry, and the slurry is forced through a narrow opening onto a wire belt. Water is rapidly removed as the forming sheet travels the length of the belt. After a distance of typically five to fifteen meters on the belt, the sheet has had enough water removed from it so that it can support its own weight. The sheet travels through a number of foils and rolls wherein more water is removed. It is dried to about 11% moisture.
The second phase in paper manufacturing involving starch is the "sizing step". Here, the paper goes through a sizing press where a starch slurry is applied to the sheet. The sheet again goes through a series of foils and rolls. It is dried on rollers and can be taken off the press as a finished product.
The third step involves coating the paper with a mixture of starch and a thermoplastic molecule. On certain lines, this occurs after the sizing step. The nascent roll can also be removed and reinstalled onto a different press for coating. A typical coating device has two blades that run the width of the paper. The blades apply the coating material onto two rolling drums. The paper passes between the drums and the coating material, comprising starch and the thermoplastic moiety, comes off the drums onto the paper. After the paper leaves the drums, it goes through a number of dryers. When the paper is dry, it goes onto a "soft calendar" comprising two drums, one made of a hard density fabric and the other a heated steel drum. The paper passes between the two drums and the heated steel drum is sufficiently hot to melt thermoplastic components of the coating mix providing a hard gloss finish on the paper.
The cellulosic wood pulp fibers, typically used in the above process, are anionic in nature. The addition of a cationic starch to the "wet end" slurry acts as an adhesive by cross linking the pulp fibers through salt linkages. Thus a cross linked polymeric network is made, comprising the starch and cellulose fibers. Typically, the cationic starches used in the "wet end" are tertiary or quaternary amines. These amino groups are added to the starch by wet millers .
Surface sizing starches are used to impart both strength and smooth finish to the sheet after it leaves the "wet end". Such starches also prepare the sheet to receive the various coatings. In cheaper grades of paper and in fiberboard manufacture, sizing starches are used simply as unmodified corn starch. For high grades of paper, chemically-modified starches are used. This is important for the application of a smooth, uniform high quality surface to the paper.
There is a tendency for starches to retrograde i.e. re¬ form high ordered structures (both helices and crystallites) in an otherwise gelatinous starch slurry. Deposition of retrograded starch onto high quality paper causes regional inconsistencies on the paper and is unacceptable. Furthermore, retrograded starch in the sizing press may necessitate shutting the line down to clear the apparatus.
The starch most often used for sizing applications is a starch having a covalently attached neutral adduct, for instance hydroxyethyl starch. This is prepared by the reaction of ethylene oxide with starch after it is isolated at the wet milling plant. The function of the hydroxyethyl (or similar) adduct is independent of its chemical nature; rather, it serves to provide steric hindrance, inhibiting the formation of high ordered structures. This steric hindrance is critical to decrease retrogradation. The periodic protuberance afforded by the adduct disrupts the formation of higher ordered structures that leads to retrogradation.
Speed is of paramount importance in paper manufacturing. Limiting in press speed is starch consistency. Presses often run below their full capacity speeds. Depending on the application, starch slurries are between 3-15% (usually 5-6%) solids. An increase in solids would necessarily result in a decrease in the amount of water that would have to be removed from a paper sheet being manufactured. This would allow the press to work at higher speeds.
Hydroxethylated starch also forms higher ordered structures as the temperature decreases or the concentration increases. The formation of the higher ordered structures on the surface of the paper is required. After application to the sheet the starch reforms some of these higher ordered structures and creates a uniform surface that imparts structural strength and facilitates the acceptance of inks and dyes. However, the higher ordered structures should not form in the slurry nor on the application device because this necessitates shutting down the production line to clear off retrograded starch.
The function of the hydroxyethyl group is to lower the temperature and/or raise the concentration of starch at which retrogradation occurs. As the processing lines have already been optimized for a particular temperature of the starch slurry, a decrease in the tendency to retrograde would allow for a higher carbohydrate content in the slurry.
The mixture applied to the paper sheet in the coating process contains hydroxethylated starch and thermoplastic molecules. The most prevalent thermoplastic molecules used are latexes, such as styrene butadiene. The function of the hydroxethyl starch is as indicated above. The function of the thermoplastic molecule is to form a high gloss finish on the paper. This causes an increased ability to take inks and dyes and improves the resolution, in general, on the printed sheet.
Based on the foregoing, there exists a need, in paper manufacturing, for modified starch substitutes which are functionally similar to modified starch. There is a further need to provide substitutes for modified starch which are less prone to retrogradation. There is a further need to provide methods of manufacturing paper which are faster than current methods and allow presses to run closer to their full capacity speed. There is a further need to provide methods of manufacturing paper that are environmentally- friendly and do not involve input materials that require chemical processing.
It is therefore an object of the present invention to provide substitutes for modified starch which are less prone to retrogradation when used in paper manufacture. It is a further object of the present invention to provide methods of manufacturing paper which are faster and more efficient than existing methods.
It is a further object of the present invention to provide substitutes for starch in paper manufacturing that do not require costly chemical modification as does starch. It is a further object of the present invention to provide methods for manufacturing paper that are more environmentally-friendly than existing methods.
It is a further object of the present invention to provide substitutes for thermoplastic molecules currently used in the coating step during paper manufacture.
Summary of the Invention
The present invention provides glucans which can be used as substitutes for modified starch and latexes in paper manufacture. The present glucans are produced by the glucosyltransferase C ("GTF C") enzyme of the species Streptococcus mutans, and are functionally similar to the modified starch currently used in paper manufacture. The present glucans also exhibit similar physical properties to thermoplastic molecules currently used in the coating step during paper manufacture.
The present invention also provides methods of making paper utilizing the present glucans, input materials that are produced biologically. Thus, the present methods are more cost-effective and environmentally-friendly than current methods, which require input materials that produce chemical effluents.
Detailed Description of the Invention
As used herein "glucan" means a glucose polymer having linkages that are QC(1—»3) , oc(l-»6) and branching oc(l—»3,6) .
As used here.in "amyloplast" means starch accumulating organelle in plant storage tissue.
As used herein, "vacuole" means the cellular compartment bounded by the tonoplast membrane. Streptococcus mutans is a species that is endogenous to the oral cavity and colonizes tooth enamel. See e.g. Kuramitsu, et al., "Characterization of Extracellular Glucosyl Transferase Activity of Streptococcus-mutans, " Infect. Immun. ; Vol. 12(4); pp. 738-749; (1975); and Yamashita, et al., "Role of the Streptococcus-Mutans-gtf Genes in Caries Induction in the Specific-Pathogen-Free Rat Model," Infect. Immun.; Vol. 61(9); pp. 3811-3817; (1993) ; both incorporated herein their entirety by reference. Streptococcus mutans species secrete the glucosyltransferase C ("GTF C") enzyme which utilizes dietary sucrose to make a variety of extracellular glucans. See e.g. Hanada, et al., "Isolation and Characterization of the Streptococcus mutans gtfc Gene, Coding for Synthesis of Both Soluble and Insoluble Glucans," Infect. Immun. ; Vol. 56(8); pp. 1999- 2005; (1988); and Kametaka, et al. , "Purification and Characterization of Glucosyltransferase from Streptococcus- mutans OMZ176 with Chromatofocusing, " Microbios; Vol. 51(206); pp. 29-36; (1978); both incorporated herein m its entirety by references.
Both soluble and insoluble glucans are synthesized, and the proteins responsible have been isolated and characterized. See e.g. Aoki, et al . , "Cloning of a Streptococcus-mutans Glucosyltransferase Gene Coding for Insoluble Glucan Synthesis" Infect. Immun. , Vol. 53 (3); pp. 587-594; (1986) ; Shimamura, et al. , "Identification of Ammo Acid Residues in Streptococcus mutans Glucosyltransferases Influencing the Structure of the Glucan Produced," J. Bacteriol.; Vol. 176(16); pp. 4845-50; (1994); and Kametaka, et al., "Purification and Characterization of Glucosyltransferase from Streptococcus-mutans OMZ176 with Chromatofocusing, " Microbios; Vol. 51 (206) ; pp. 29-36; (1987); all incorporated herein their entirety by reference. The proteins involved are large (~155 kDa) and catalyze the group transfer of the glucosyl portion of sucrose to an acceptor glucan via ∞ (1—>3) and oc (1→6) linkages. See e.g. Wenham, et al., "Regulation of Glucosyl Transferase and Fructosyl Transferase Synthesis by Continuous Cultures of Streptococcus-mutans," J^_ Gen Microbiol. ; Vol. 114 (Part 1); pp. 117-124; (1979); and Fu, et al . , "Maltodextrm Acceptor Reactions of Streptococcus-mutans 6715 glucosyltransferases," Carbohydr. Res. ; Vol. 217; pp. 210- 211; (1991); and Bhattachariee, et al., "Formation of Alpha - (l->6), Alpha - (l->3), and Alpha (l->2) Glycosidic Linkages by Dextransucrase from Streptococcus Sanguis in Acceptor- Dependent Reactions," Carbohydr. Res. , Vol. 242; pp. 191- 201; (1993); all incorporated herein their entirety by reference.
The genes involved in glucan synthesis have been isolated and sequenced. See Shimamura, et al. , cited hereinabove and Russel, et al., "Expression of a Gene for Glucan-bmdmg Protein from Streptococcus-mutans in Escherichia-coli, " J_^ Gen. Microbiol. ; Vol. 131(2); pp. 295-300; (1985) ; Russell, et al. , "Characterization of Glucosyltransferase Expressed from a Streptococcus-Sobπnus Gene Cloned in Escherichia-coli, " J. Gen. Microbiol . ; Vol. 133(4); pp. 935-944; (1987) ; and Shiroza, et al . , "Sequence Analysis of the gtfc Gene from Streptococcus mutans," J. Bacteriol.; Vol. 169(9); pp. 4263-4270; (1987); all incorporated herein in their entirety by reference.
The structure of the glucans produced by the GTF C enzyme is quite heterogeneous with respect to the proportions of <x(l—>3), oc(l—>6) and oc(l—>3, 6) branches present m any given glucan. Transformation of genes which encode naturally occurring GTF C into plants, such as maize, provides amyloplasts and vacuoles with novel compositions.
GTF C enzyme activity incorporated into the amyloplast and/or vacuole leads to the accumulation of starch and glucan in the same amyloplast and/or vacuole. Retrogradation occurs as portions of starch molecules interact and subsequently form inter- or intra-chain helices. In a mixture of starch and glucans, the frequency of starch-starch interactions that lead to helix formation is diminished. A paste made from the mixed polymers is less prone to retrogradation as a result. This is especially true in the starch accumulation mutants envisioned as transformation targets where the relative proportion of starch is reduced.
Glucans produced in maize amyloplasts and/or vacuoles by the transgenic GTF C enzyme can function in paper processing without chemical modification, as required of starch. The polymer solution consequently has altered rheological properties and is less prone to retrogradation compared to starch. The glucans are branched and irregular and able to supplant modified starches with comparable or superior efficacy. They do not require any costly chemical modification as does starch. For coating applications, the present glucans exhibit thermoplastic properties in addition to the above advantages. The wild type of GTF C is useful m producing glucans according to the present invention. The GTF C enzyme is well known. See e.g. Shimamura et al . , and Hanada, et al . , cited hereinabove. The glucans produced are particularly useful as substitutes for modified starches in the coating step of paper manufacture. The present glucans are also useful as substitutes for thermoplastic molecules such as latex (e.g. styrene butadiene). The subject glucans impact a high gloss finish on the paper and increase the ability of the paper to take on dyes and inks and improves the resolution in general on the printed sheet.
The glucans of the present invention are preferably produced in transgenic maize, potato, cassava, sweet potato, rye, barley, wheat, sorghum, oats, millet, triticale, sugarcane and rice. More preferably, the present glucans are produced in maize, potato, sugarcane, cassava, and sweet potato. Even more preferably, the present glucans are produced in maize and potato. Most preferably, the present glucans are produced in maize.
In a highly preferred embodiment of the present invention, maize lines deficient in starch biosynthesis are transformed with GTF C genes. Such lines may be naturally occurring maize mutants (i.e. sh2, bty, btL ) or transgenic maize engineered so as to accumulate low amounts of starch in the endosperm when compared to wild type maize. See e.g. Muller-Rober, et al., "Inhibition of the ADP-glucose Pyrophosphorylase in Transgenic Potatoes Leads to Sugar- Storing Tubers and Influences Tuber Formation and Expression of Tuber Storage Protein Genes," The EMBO Journal; Vol. 11(4); pp. 1229-1238; (1992); and Creech, "Carbohydrate Synthesis in Maize," Advances in Agronomy; Vol. 20; pp. 275- 322; (1968); both incorporated herein in their entirety by reference.
The production of the present glucans is performed according to methods of transformation that are well known in the art, and thus constitute no part of this invention. The compounds of the present invention are synthesized by insertion of an expression cassette containing a synthetic gene which, when transcribed and translated, yields a GTF enzyme that produces the desired glucan. Such empty expression cassettes, providing appropriate regulatory sequences for plant expression of the desired sequence, are also well-known, and the nucleotide sequence for the synthetic gene, either RNA or DNA, can readily be derived from the amino acid sequence for the protein using standard texts and the references provided. The above-mentioned synthetic genes preferably employ plant-preferred codons to enhance expression of the desired protein.
The following description further exemplifies the compositions of this invention and the methods of making and using them. However, it will be understood that other methods, known by those of ordinary skill in the art to be equivalent, can also be employed.
The genes which code for the present enzyme can be inserted into an appropriate expression cassette and introduced into cells of a plant species. Thus, an especially preferred embodiment of this method involves inserting into the genome of the plant a DNA sequence coding for a mutant or wild type in proper reading frame, together with transcription promoter and initiator sequences active in the plant. Transcription and translation of the DNA sequence under control of the regulatory sequences causes expression of the protein sequence at levels which provide an elevated amount of the protein in the tissues of the plant.
Synthetic DNA sequences can then be prepared which code for the appropriate sequence of amino acids of GTF C protein, and this synthetic DNA sequence can be inserted into an appropriate plant expression cassette. Plant expression cassettes and vectors applicable in the present invention are well known in the art. By the term "expression cassette" is meant a complete set of control sequences including promoter, initiation, and termination sequences which function in a plant cell when they flank a structural gene in the proper reading frame. Expression cassettes frequently and preferably contain an assortment of restriction sites suitable for cleavage and insertion of any desired structural gene. It is important that the cloned gene have a start codon m the correct reading frame for the structural sequence.
By the term "vector" herein is meant a DNA sequence which is able to replicate and express a foreign gene in a host cell. Typically, the vector has one or more restriction endonuclease recognition sites which may be cut in a predictable fashion by use of the appropriate enzyme such vectors are preferably constructed to include additional structural gene sequences imparting antibiotic or herbicide resistance, which then serve as markers to identify and separate transformed cells. Preferred markers/selection agents include kanamycm, chlorosulfuron, phosphonothricm, hygromycin and methotrexate. A cell in which the foreign genetic material in a vector is functionally expressed has been "transformed" by the vector and is referred to as a "transformant" .
A particularly preferred vector is a plasmid, by which is meant a circular double-stranded DNA molecule which is not a part of the chromosomes of the cell.
As mentioned above, both genomic DNA and cDNA encoding the gene of interest may be used in this invention. The gene of interest may also be constructed partially from a cDNA clone and partially from a genomic clone. When the gene of interest has been isolated, genetic constructs are made which contain the necessary regulatory sequences to provide for efficient expression of the gene in the host cell. According to this invention, the genetic construct will contain (a) a genetic sequence coding for the protein or trait of interest and (b) one or more regulatory sequences operably linked on either side of the structural gene of interest. Typically, the regulatory sequences will be selected from the group comprising of promoters and terminators. The regulatory sequences may be from autologous or heterologous sources.
The expression cassette comprising the structural gene for a mutant of this invention operably linked to the desired control sequences can be ligated into a suitable cloning vector. In general, plasmid or viral (bacteriophage) vectors containing replication and control sequences derived from species compatible with the host cell are used. The cloning vector will typically carry a replication origin, as well as specific genes that are capable of providing phenotypic selection markers in transformed host cells. Typically, genes conferring resistance to antibiotics or selected herbicides are used. After the genetic material is introduced into the target cells, successfully transformed cells and/or colonies of cells can be isolated by selection on the basis of these markers .
Typically, an intermediate host cell will be used in the practice of this invention to increase the copy number of the cloning vector. With an increased copy number, the vector containing the gene of interest can be isolated in significant quantities for introduction into the desired plant cells. Host cells that can be used in the practice of this invention include prokaryotes, including bacterial hosts such as E. coli, S. typhimurium, and Serratia marcescens. Eukaryotic hosts such as yeast or filamentous fungi may also be used in this invention. Since these hosts are also microorganisms, it will be essential to ensure that plant promoters which do not cause expression of the protein in bacteria are used in the vector.
The isolated cloning vector will then be introduced into the plant cell using any convenient technique, including electroporation (in protoplasts) , retroviruses, bombardment, and microinjection into cells from monocotyledonous or dicotyledonous plants in cell or tissue culture to provide transformed plant cells containing as foreign DNA at least one copy of the DNA sequence of the plant expression cassette. Using known techniques, protoplasts can be regenerated and cell or tissue culture can be regenerated to form whole fertile plants which carry and express the gene for a protein according to this invention. Accordingly, a highly preferred embodiment of the present invention is a transformed maize plant, the cells of which contain as foreign DNA at least one copy of the DNA sequence of an expression cassette of the GTF C protein. It will also be appreciated by those of ordinary skill that the plant vectors provided herein can be incorporated into Agrobacterium tumefaciens, which can then be used to transfer the vector into susceptible plant cells, primarily from dicotyledonous species. Thus, this invention provides a method for introducing GTF C in Agrobacterium tumefaciens- susceptible dicotyledonous plants in which the expression cassette is introduced into the cells by infecting the cells with Agrobacterium tumefaciens, a plasmid of which has been modified to include a plant expression cassette of this invention.
For example, the potato plant can be transformed via Agrobacterium tumefaciens to produce the present glucans. The transformation cassette comprises a patatin promoter, followed by the GTF C coding sequence and the neomycin phosphotransferase polyadenylation site/terminator. See e.g. Utsumi, et al., "Expression and Accumulation for Normal and Modified Soybean Glycinins in Potato Tubers," Plant Science; Vol. 102(2); pp. 181-188; (1994); (Limerick); incorporated herein in its entirety by reference. The transgenic cassette is placed into a transformation vector. For example, BIN19, or derivatives thereof, are useful when transforming via Agrobacterium tumefaciens. See e.g. Visser, et al . , "Transformation of Homozygous Diploid Potato with an Agrobacterium-tumefaciens Binary Vector System by Adventitious Shoot Regeneration on Leaf and Stem Segments, " Plant Mol. Biol. ; Vol. 12(3); pp. 329-338; (1989); incorporated herein in its entirety by reference.
For maize transformation vectors, the promoters include any promoter whose expression is specific and limited to endosperm cells. Included are those encoding either 22 kDa zein, opaque2, gamma zein and waxy. These lead into the GTF C gene and are followed by the endogenous terminator or the heterogeneous PINII terminator.
The GTF C protein is directed to the maize endosperm amyloplast using a suitable transit sequence. Transit sequences useful in directing the enzyme into the amyloplast for accumulation within the amyloplast include but are not limited to ribulose biphosphate carboxylase small subunit, waxy, brittle-1, and chlorophyll AB binding protein. The transit sequences are juxtaposed between the promoter and the GTF C coding sequence and fused in translational reading frame with the GTF C moiety. Transit sequences useful in directing the enzyme into the vacuole for accumulation within the vacuole are well known in the art. For vacuolar targeting, see e.g. Ebskamp, et al., "Accumulation of Fructose Polymers in Transgenic Tobacco," Bio/technology; Vol. 12; pp. 272-275; (1994); incorporated herein in its entirety by reference.
For maize transformation and regeneration see e.g. Armstrong, C, (1994), "Regeneration of Plants from Somatic Cell Cultures: Applications for iτι vitro Genetic Manipulation," The Maize Handbook, Freeling, et al. eds, pp. 663-671; incorporated herein in its entirety by reference.
Once a given plant is transformed, the glucans synthesized can be isolated, by standard methods, known to one skilled in the art. The glucans thus obtained in the transgenic plant can be substituted for modified starches and utilized in the sizing and/or coating steps. For formulations useful in the coating step, see e.g. Heiser, et al., "Starch Formations," Starch and Starch Products in Paper Coating; Kearney, et al. , eds., pp. 147-162; (1990); Tappi Press; incorporated herein in its entirety by reference.
The present glucans are utilized in an amount of from about 4 to about 15 weight percent, more preferably from about 5 to about 12 weight percent, also preferably from about 6 to about 8 weight percent. Weight percent is defined as grams of molecule per 100 ml coating solution. The present glucans are used to replace the starch and/or latex molecules completely, or a starch-glucan or a latex-glucan mixture is used in the slurry. In the coating application, the glucan:starch ratio preferably ranges from about 10:90 to about 100:0; more preferably from about 40:60 to about 100:0; more preferably still from about 60:40 to about 100:0; most preferably about 100:0. The glucan:latex ratio preferably ranges from about 10:90 to about 100:0; more preferably from about 40:60 to about 100:0; more preferably still from about 60:40 to about 100:0; most preferably about 100:0.
All publications cited in this application are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Variations on the above embodiments are within the ability of one of ordinary skill in the art, and such variations do not depart from the scope of the present invention as described in the following claims.

Claims

WHAT CLAIMED IS:
1. A method of manufacturing paper comprising adding a glucan synthesized by the wild type of glucosyltransferase C enzyme, to one or more of the steps in paper manufacturing wherein modified starch is used.
2. The method of Claim 1 wherein the glucan is added to the coating step.
3. The method of Claim 3 wherein the amount of glucan utilized is from about 4 to about 15 weight percent of the coating composition.
4.
The method of the Claim 3 wherein the glucan is produced in a plant selected from the group consisting of maize, potato, cassava, sweet potato, rye, barley, sugarcane, wheat, sorghum, oats, millet, triticale and rice.
5.
The method of Claim 4 wherein the glucan is produced by transformation with Agrobacterium tumefaciens, microparticle injection, electroporation, bombardment or retroviruses.
6. The method of claim 5 wherein the amount of glucan utilized is from about 5 to about 12 weight percent of the coating composition.
7. The method of Claim 6 wherein the transformation is performed using a transit sequence selected from the group consisting of ribulose biphosphate carboxylase small subunit, waxy, brittle-1 and chlorophyll AB binding protein.
8. The method of Claim 7 wherein the transgenic plant has been genetically engineered to down regulate or abolish starch biosynthesis.
9. The method of Claim 8 wherein the glucan is produced in potato or maize.
10. The method of Claim 9 wherein the GTF C is produced by using a promoter selected from the group consisting of 22kDa zein, opaque 2, gamma zein and waxy.
11. The method of Claim 10 wherein the glucan is produced in the amyloplast of maize.
12. A method of imparting gloss on paper during the manufacturing process comprising adding a glucan synthesized by the wild type of glucosyltransferase C enzyme to the coating step instead of latex molecules.
13. The method of Claim 12 wherein the amount of glucan utilized is from about 4 to about 15 weight percent of the coating composition.
14.
The method of Claim 13 wherein the glucan is produced in a plant selected from the group consisting of maize, potato, cassava, sweet potato, sugarcane, rye, barley, wheat, sorghum, oats, millet, triticale, and rice.
15.
The method of Claim 14 wherein the glucan is produced by a transformation with Agrobacterium tumefaciens, electroporation, microparticle injection, bombardment or retroviruses.
16.
The method of Claim 15 wherein the amount of glucan utilized is from about 5 to about 12 weight percent of the coating composition.
17. The method of Claim 16 wherein the transformation is performed using a transit sequence selected from the group consisting of ribulose biphosphate carboxylase small subunit, waxy, brittle-1, and chlorophyll AB binding protein.
18. The method of Claim 17 wherein the glucan is produced in potato or maize.
19. The method of Claim 18 wherein the glucan is produced by using a promoter selected from the group consisting of 22 kDa zein, opaque 2, gamma zein and waxy.
20.
A glucan synthesized in the amyloplast or vacuole of a transgenic plant by the glucosyltransferase C enzyme.
EP96925260A 1996-06-12 1996-06-12 Substitutes for modified starch in paper manufacture Withdrawn EP0904454A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1996/010191 WO1997047807A1 (en) 1996-06-12 1996-06-12 Substitutes for modified starch in paper manufacture

Publications (1)

Publication Number Publication Date
EP0904454A1 true EP0904454A1 (en) 1999-03-31

Family

ID=22255318

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96925260A Withdrawn EP0904454A1 (en) 1996-06-12 1996-06-12 Substitutes for modified starch in paper manufacture

Country Status (5)

Country Link
EP (1) EP0904454A1 (en)
JP (1) JP2000512348A (en)
AU (1) AU729286B2 (en)
CA (1) CA2257622C (en)
WO (1) WO1997047807A1 (en)

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007003743A1 (en) 2006-12-22 2008-07-11 Bayer Cropscience Ag COMPOSITION THAT INCLUDES FENAMIDONA AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY.
CL2007003744A1 (en) 2006-12-22 2008-07-11 Bayer Cropscience Ag COMPOSITION THAT INCLUDES A 2-PYRIDILMETILBENZAMIDE DERIVATIVE AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY.
WO2008110280A2 (en) 2007-03-12 2008-09-18 Bayer Cropscience Ag Phenoxy substituted phenylamidine derivatives and their use as fungicides
EP1969929A1 (en) 2007-03-12 2008-09-17 Bayer CropScience AG Substituted phenylamidines and their use as fungicides
US9199922B2 (en) 2007-03-12 2015-12-01 Bayer Intellectual Property Gmbh Dihalophenoxyphenylamidines and use thereof as fungicides
US8080688B2 (en) 2007-03-12 2011-12-20 Bayer Cropscience Ag 3, 4-disubstituted phenoxyphenylamidines and use thereof as fungicides
EP1969930A1 (en) 2007-03-12 2008-09-17 Bayer CropScience AG Phenoxy phenylamidines and their use as fungicides
EP1969934A1 (en) 2007-03-12 2008-09-17 Bayer CropScience AG 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides
WO2008128639A1 (en) 2007-04-19 2008-10-30 Bayer Cropscience Aktiengesellschaft Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
DE102007045919B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
DE102007045922A1 (en) 2007-09-26 2009-04-02 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE102007045920B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistic drug combinations
DE102007045956A1 (en) 2007-09-26 2009-04-09 Bayer Cropscience Ag Combination of active ingredients with insecticidal and acaricidal properties
DE102007045953B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
EP2090168A1 (en) 2008-02-12 2009-08-19 Bayer CropScience AG Method for improving plant growth
EP2072506A1 (en) 2007-12-21 2009-06-24 Bayer CropScience AG Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide
EP2168434A1 (en) 2008-08-02 2010-03-31 Bayer CropScience AG Use of azols to increase resistance of plants of parts of plants to abiotic stress
EP2321262A1 (en) 2008-08-14 2011-05-18 Bayer CropScience AG Insecticidal 4-phenyl-1h-pyrazoles
DE102008041695A1 (en) 2008-08-29 2010-03-04 Bayer Cropscience Ag Methods for improving plant growth
EP2201838A1 (en) 2008-12-05 2010-06-30 Bayer CropScience AG Active ingredient-beneficial organism combinations with insecticide and acaricide properties
EP2198709A1 (en) 2008-12-19 2010-06-23 Bayer CropScience AG Method for treating resistant animal pests
EP2223602A1 (en) 2009-02-23 2010-09-01 Bayer CropScience AG Method for improved utilisation of the production potential of genetically modified plants
EP2204094A1 (en) 2008-12-29 2010-07-07 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants Introduction
WO2010075966A1 (en) 2008-12-29 2010-07-08 Bayer Cropscience Ag Method for improved use of the production potential of genetically modified plants
EP2039772A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants introduction
EP2039770A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2039771A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
US8487118B2 (en) 2009-01-19 2013-07-16 Bayer Cropscience Ag Cyclic diones and their use as insecticides, acaricides and/or fungicides
EP2227951A1 (en) 2009-01-23 2010-09-15 Bayer CropScience AG Application of enaminocarbonyl compounds for combating viruses transmitted by insects
ES2406131T3 (en) 2009-01-28 2013-06-05 Bayer Intellectual Property Gmbh Fungicidal derivatives of N-cycloalkyl-N-bicyclomethylene-carboxamine
AR075126A1 (en) 2009-01-29 2011-03-09 Bayer Cropscience Ag METHOD FOR THE BEST USE OF THE TRANSGENIC PLANTS PRODUCTION POTENTIAL
CN102317259B (en) 2009-02-17 2015-12-02 拜尔农科股份公司 Fungicidal N-(phenylcycloalkyl) carboxylic acid amides, N-(benzylic cycloalkyl group) carboxylic acid amides and thiocarboxamide derivative
EP2218717A1 (en) 2009-02-17 2010-08-18 Bayer CropScience AG Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
TW201031331A (en) 2009-02-19 2010-09-01 Bayer Cropscience Ag Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
MX2011009916A (en) 2009-03-25 2011-10-06 Bayer Cropscience Ag Active ingredient combinations having insecticidal and acaricidal properties.
EP2232995A1 (en) 2009-03-25 2010-09-29 Bayer CropScience AG Method for improved utilisation of the production potential of transgenic plants
MX2011009372A (en) 2009-03-25 2011-09-27 Bayer Cropscience Ag Active ingredient combinations having insecticidal and acaricidal properties.
EP2410850A2 (en) 2009-03-25 2012-02-01 Bayer Cropscience AG Synergistic combinations of active ingredients
BRPI0924436B1 (en) 2009-03-25 2017-06-06 Bayer Cropscience Ag combinations of active substances with insecticidal and acaricidal properties and their use, as well as method for pest and animal control
JP2012521371A (en) 2009-03-25 2012-09-13 バイエル・クロップサイエンス・アーゲー Combination of active compounds having insecticidal and acaricidal properties
EP2239331A1 (en) 2009-04-07 2010-10-13 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2427059B1 (en) 2009-05-06 2015-06-03 Bayer Intellectual Property GmbH Cyclopentanedione compounds and their use as insecticides and acaricides
EP2251331A1 (en) 2009-05-15 2010-11-17 Bayer CropScience AG Fungicide pyrazole carboxamides derivatives
AR076839A1 (en) 2009-05-15 2011-07-13 Bayer Cropscience Ag FUNGICIDE DERIVATIVES OF PIRAZOL CARBOXAMIDAS
EP2255626A1 (en) 2009-05-27 2010-12-01 Bayer CropScience AG Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress
PL2437595T3 (en) 2009-06-02 2019-05-31 Bayer Cropscience Ag Use of fluopyram for controlling sclerotinia ssp
CN104430378A (en) 2009-07-16 2015-03-25 拜尔农作物科学股份公司 Synergistic active substance combinations containing phenyl triazoles
WO2011015524A2 (en) 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
EP2292094A1 (en) 2009-09-02 2011-03-09 Bayer CropScience AG Active compound combinations
EP2343280A1 (en) 2009-12-10 2011-07-13 Bayer CropScience AG Fungicide quinoline derivatives
BR112012012107B1 (en) 2009-12-28 2019-08-20 Bayer Cropscience Ag Compound, fungicidal composition and method for controlling plant pathogenic fungi
EP2519516A2 (en) 2009-12-28 2012-11-07 Bayer CropScience AG Fungicidal hydroximoyl-tetrazole derivatives
TWI528898B (en) 2009-12-28 2016-04-11 拜耳知識產權公司 Fungicide thiol (HYDROXIMOYL)-heterocyclic derivative
WO2011089071A2 (en) 2010-01-22 2011-07-28 Bayer Cropscience Ag Acaricide and/or insecticide active substance combinations
AR080443A1 (en) 2010-03-04 2012-04-11 Bayer Cropscience Ag 2-AMIDOBENCIMIDAZOLES REPLACED WITH FLURUOALQUILO
CN102933078A (en) 2010-04-06 2013-02-13 拜耳知识产权有限责任公司 Use of 4-phenylbutyric acid and/or the salts thereof for enhancing the stress tolerance of plants
WO2011124553A2 (en) 2010-04-09 2011-10-13 Bayer Cropscience Ag Use of derivatives of the (1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress
WO2011134911A2 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
JP2013525400A (en) 2010-04-28 2013-06-20 バイエル・クロップサイエンス・アーゲー Fungicide hydroxymoyl-heterocyclic derivative
WO2011134913A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
JP5730992B2 (en) 2010-06-03 2015-06-10 バイエル・クロップサイエンス・アーゲーBayer Cropscience Ag N-[(Heta) arylethyl)] pyrazole (thio) carboxamides and their hetero-substituted analogues
EP2576517B1 (en) 2010-06-03 2014-12-17 Bayer Intellectual Property GmbH N-[(het)arylalkyl)]pyrazole (thio)carboxamides and their heterosubstituted analogues
UA110703C2 (en) 2010-06-03 2016-02-10 Байєр Кропсайнс Аг Fungicidal n-[(trisubstitutedsilyl)methyl]carboxamide
CA2801834A1 (en) 2010-06-09 2011-12-15 Kathleen D'halluin Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
BR112012031323A2 (en) 2010-06-09 2015-09-08 Bayer Cropscience Nv methods and means for modifying plant genomes in a nucleotide sequence commonly used in plant genetic engineering
MX2013000655A (en) 2010-07-20 2013-03-22 Bayer Cropscience Ag Benzocycloalkenes as antifungal agents.
PL2611300T3 (en) 2010-09-03 2016-10-31 Substituted annelated dihydropyrimidinone compounds
EP2460406A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Use of fluopyram for controlling nematodes in nematode resistant crops
CN103298341B (en) 2010-09-22 2016-06-08 拜耳知识产权有限责任公司 Active component is used for preventing and treating the purposes of nematicide in nematicide crop
BR112013008446B1 (en) 2010-10-07 2018-06-12 Bayer Cropscience Ag '' COMPOSITION AND METHOD FOR CONTROLING PHYTOPATHOGENIC FUNGALS OR DAMAGING INSECTS OF PLANTS, CROPS OR SEEDS ''
MX2013004278A (en) 2010-10-21 2013-06-05 Bayer Ip Gmbh N-benzyl heterocyclic carboxamides.
CN103313977B (en) 2010-10-21 2015-06-03 拜耳知识产权有限责任公司 1-(heterocyclic carbonyl) piperidines
US9320276B2 (en) 2010-11-02 2016-04-26 Bayer Intellectual Property Gmbh N-hetarylmethyl pyrazolylcarboxamides
JP5860471B2 (en) 2010-11-15 2016-02-16 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH N-arylpyrazole (thio) carboxamides
WO2012065945A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazole(thio)carboxamides
US9375004B2 (en) 2010-11-15 2016-06-28 Bayer Intellectual Property Gmbh 5-halogenopyrazolecarboxamides
EP2460407A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Agent combinations comprising pyridylethyl benzamides and other agents
MX2013005356A (en) 2010-12-01 2013-07-05 Bayer Ip Gmbh Use of fluopyram for controlling nematodes in crops and for increasing yield.
WO2012089757A1 (en) 2010-12-29 2012-07-05 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
EP2474542A1 (en) 2010-12-29 2012-07-11 Bayer CropScience AG Fungicide hydroximoyl-tetrazole derivatives
EP2471363A1 (en) 2010-12-30 2012-07-04 Bayer CropScience AG Use of aryl-, heteroaryl- and benzylsulfonamide carboxylic acids, -carboxylic acid esters, -carboxylic acid amides and -carbonitriles and/or its salts for increasing stress tolerance in plants
EP2494867A1 (en) 2011-03-01 2012-09-05 Bayer CropScience AG Halogen-substituted compounds in combination with fungicides
EP2683239A1 (en) 2011-03-10 2014-01-15 Bayer Intellectual Property GmbH Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds
US20140005230A1 (en) 2011-03-14 2014-01-02 Juergen Benting Fungicide hydroximoyl-tetrazole derivatives
JP2014512358A (en) 2011-04-08 2014-05-22 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー Fungicide hydroxymoyl-tetrazole derivative
EP2511255A1 (en) 2011-04-15 2012-10-17 Bayer CropScience AG Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives
AR090010A1 (en) 2011-04-15 2014-10-15 Bayer Cropscience Ag 5- (CICLOHEX-2-EN-1-IL) -PENTA-2,4-DIENOS AND 5- (CICLOHEX-2-EN-1-IL) -PENT-2-EN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST THE ABIOTIC STRESS OF PLANTS, USES AND TREATMENT METHODS
AR085585A1 (en) 2011-04-15 2013-10-09 Bayer Cropscience Ag VINIL- AND ALQUINILCICLOHEXANOLES SUBSTITUTED AS ACTIVE PRINCIPLES AGAINST STRIPS ABIOTIQUE OF PLANTS
AR085568A1 (en) 2011-04-15 2013-10-09 Bayer Cropscience Ag 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENTA-2,4-DIENOS AND 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENT- 2-IN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST ABIOTIC STRESS OF PLANTS
TR201901837T4 (en) 2011-04-22 2019-03-21 Bayer Cropscience Ag Active compound preparations containing a (thio) carboxamide derivative and a fungicidal compound.
TR201802544T4 (en) 2011-06-06 2018-03-21 Bayer Cropscience Nv Methods and tools for modifying a plant genome in a preselected region.
EP2729007A1 (en) 2011-07-04 2014-05-14 Bayer Intellectual Property GmbH Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
AU2012293636B2 (en) 2011-08-10 2015-12-03 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
WO2013026836A1 (en) 2011-08-22 2013-02-28 Bayer Intellectual Property Gmbh Fungicide hydroximoyl-tetrazole derivatives
EP2748323B1 (en) 2011-08-22 2019-05-01 BASF Agricultural Solutions Seed US LLC Methods and means to modify a plant genome
EP2561759A1 (en) 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
WO2013034621A1 (en) 2011-09-09 2013-03-14 Bayer Intellectual Property Gmbh Acyl-homoserine lactone derivatives for improving plant yield
KR101978006B1 (en) 2011-09-12 2019-05-13 바이엘 인텔렉쳐 프로퍼티 게엠베하 Fungicidal 4-substituted-3-{phenyl[(heterocyclylmethoxy)imino]methyl}-1,2,4-oxadiazol-5(4h)-one derivatives
WO2013037958A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of phenylpyrazolin-3-carboxylates for improving plant yield
AR087872A1 (en) 2011-09-16 2014-04-23 Bayer Ip Gmbh USE OF 5-PHENYL-OR 5-BENCIL-2 ISOXAZOLIN-3 CARBOXYLATES TO IMPROVE THE PERFORMANCE OF PLANTS
AU2012307321B2 (en) 2011-09-16 2016-07-14 Bayer Intellectual Property Gmbh Use of acylsulfonamides for improving plant yield
EP2757886A1 (en) 2011-09-23 2014-07-30 Bayer Intellectual Property GmbH Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
AR088113A1 (en) 2011-10-04 2014-05-07 Bayer Ip Gmbh INTERFERENCE RNA (RNAi) FOR THE CONTROL OF FUNGES AND OOMYCES BY THE INHIBITION OF THE SACAROPINE DEHYDROGENASE GENE
WO2013050324A1 (en) 2011-10-06 2013-04-11 Bayer Intellectual Property Gmbh Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress
EP2782920B1 (en) 2011-11-21 2016-12-21 Bayer Intellectual Property GmbH Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives
CN104066721B (en) 2011-11-30 2016-03-30 拜耳知识产权有限责任公司 The N-bicyclic alkyl of fungicidal and N-tricyclic alkyl pyrazoles-4-(sulfo-) carboxamide derivative
AU2012357896B9 (en) 2011-12-19 2016-12-15 Bayer Cropscience Ag Use of anthranilic acid diamide derivatives for pest control in transgenic crops
EP2797891B1 (en) 2011-12-29 2015-09-30 Bayer Intellectual Property GmbH Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
WO2013098146A1 (en) 2011-12-29 2013-07-04 Bayer Intellectual Property Gmbh Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
NZ722687A (en) 2012-02-22 2017-03-31 Bayer Ip Gmbh Use of succinate dehydrogenase inhibitors (sdhis) for controlling wood diseases in grape.
BR122019010640B1 (en) 2012-02-27 2020-12-22 Bayer Intellectual Property Gmbh combination, method to control harmful phytopathogenic fungi and use of said combination
WO2013139949A1 (en) 2012-03-23 2013-09-26 Bayer Intellectual Property Gmbh Compositions comprising a strigolactame compound for enhanced plant growth and yield
EP2836489B1 (en) 2012-04-12 2016-06-29 Bayer Cropscience AG N-acyl-2-(cyclo) alkylpyrrolidines and piperidines useful as fungicides
EP2838363A1 (en) 2012-04-20 2015-02-25 Bayer Cropscience AG N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives
AU2013251109B2 (en) 2012-04-20 2017-08-24 Bayer Cropscience Ag N-cycloalkyl-N-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
EP2841581B2 (en) 2012-04-23 2023-03-08 BASF Agricultural Solutions Seed US LLC Targeted genome engineering in plants
WO2013167544A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag 5-halogenopyrazole indanyl carboxamides
EP2662364A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole tetrahydronaphthyl carboxamides
EP2662363A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole biphenylcarboxamides
EP2662361A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazol indanyl carboxamides
EP2662362A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole indanyl carboxamides
WO2013167545A1 (en) 2012-05-09 2013-11-14 Bayer Cropscience Ag Pyrazole indanyl carboxamides
EP2662360A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole indanyl carboxamides
EP2662370A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole benzofuranyl carboxamides
AR091104A1 (en) 2012-05-22 2015-01-14 Bayer Cropscience Ag COMBINATIONS OF ACTIVE COMPOUNDS THAT INCLUDE A LIPO-CHYTOOLIGOSACARIDE DERIVATIVE AND A NEMATICIDE, INSECTICIDE OR FUNGICIDE COMPOUND
AU2013289301A1 (en) 2012-07-11 2015-01-22 Bayer Cropscience Ag Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress
BR112015004858A2 (en) 2012-09-05 2017-07-04 Bayer Cropscience Ag use of 2-amidobenzimidazoles, 2-amidobenzoxazoles and substituted 2-amidobenzothiazoles or salts thereof as active substances against abiotic stress in plants
CA2888562C (en) 2012-10-19 2020-10-27 Bayer Cropscience Ag Method for treating plants against fungi resistant to fungicides using carboxamide or thiocarboxamide derivatives
UA114937C2 (en) 2012-10-19 2017-08-28 Байєр Кропсайнс Аг Method of plant growth promotion using carboxamide derivatives
PL2908642T3 (en) 2012-10-19 2022-06-13 Bayer Cropscience Ag Method for enhancing tolerance to abiotic stress in plants by using carboxamide or thiocarboxamide derivatives
UA114822C2 (en) 2012-10-19 2017-08-10 Байєр Кропсайнс Аг Active compound combinations comprising carboxamide derivatives
WO2014079957A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Selective inhibition of ethylene signal transduction
EP2735231A1 (en) 2012-11-23 2014-05-28 Bayer CropScience AG Active compound combinations
CA2892712A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Ternary fungicidal and pesticidal mixtures
WO2014083033A1 (en) 2012-11-30 2014-06-05 Bayer Cropsience Ag Binary fungicidal or pesticidal mixture
EA201500580A1 (en) 2012-11-30 2016-01-29 Байер Кропсайенс Акциенгезельшафт DOUBLE FUNGICIDE MIXTURES
MX2015006327A (en) 2012-11-30 2015-10-05 Bayer Cropscience Ag Ternary fungicidal mixtures.
CA2892701A1 (en) 2012-11-30 2014-06-05 Bayer Cropscience Ag Binary pesticidal and fungicidal mixtures
JP2016500368A (en) 2012-12-05 2016-01-12 バイエル・クロップサイエンス・アクチェンゲゼルシャフト As substituted 1- (arylethynyl)-, 1- (heteroarylethynyl)-, 1- (heterocyclic ethynyl)-and 1- (cycloalkenylethynyl) -cyclohexanol as active agents against abiotic plant stress use
EP2740356A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives
EP2740720A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants
WO2014090765A1 (en) 2012-12-12 2014-06-19 Bayer Cropscience Ag Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops
AR093996A1 (en) 2012-12-18 2015-07-01 Bayer Cropscience Ag BACTERICIDAL COMBINATIONS AND BINARY FUNGICIDES
EP2935218A1 (en) 2012-12-19 2015-10-28 Bayer CropScience AG Difluoromethyl-nicotinic- tetrahydronaphtyl carboxamides
US20160016944A1 (en) 2013-03-07 2016-01-21 Bayer Cropscience Aktiengesellschaft Fungicidal 3--heterocycle derivatives
US20160053274A1 (en) 2013-04-02 2016-02-25 Bayer Cropscience Nv Targeted genome engineering in eukaryotes
JP6397482B2 (en) 2013-04-12 2018-09-26 バイエル・クロップサイエンス・アクチェンゲゼルシャフト New triazole derivatives
EP2984080B1 (en) 2013-04-12 2017-08-30 Bayer CropScience Aktiengesellschaft Novel triazolinthione derivatives
KR20150144779A (en) 2013-04-19 2015-12-28 바이엘 크롭사이언스 악티엔게젤샤프트 Binary insecticidal or pesticidal mixture
BR112015026235A2 (en) 2013-04-19 2017-10-10 Bayer Cropscience Ag method for improving utilization of the potential of transgenic plant production involving the application of a phthaldiamide derivative
TW201507722A (en) 2013-04-30 2015-03-01 Bayer Cropscience Ag N-(2-halogen-2-phenethyl)carboxamides as nematicides and endoparasiticides
WO2014177514A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag Nematicidal n-substituted phenethylcarboxamides
US9770022B2 (en) 2013-06-26 2017-09-26 Bayer Cropscience Ag N-cycloalkyl-N-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2015004040A1 (en) 2013-07-09 2015-01-15 Bayer Cropscience Ag Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress
RU2685723C1 (en) 2013-12-05 2019-04-23 Байер Кропсайенс Акциенгезелльшафт N-cycloalkyl-n-{[2-(1-substituted cycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
EP3077377B1 (en) 2013-12-05 2020-01-22 Bayer CropScience Aktiengesellschaft N-cycloalkyl-n-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
AR101214A1 (en) 2014-07-22 2016-11-30 Bayer Cropscience Ag CIANO-CICLOALQUILPENTA-2,4-DIENOS, CIANO-CICLOALQUILPENT-2-EN-4-INAS, CIANO-HETEROCICLILPENTA-2,4-DIENOS AND CYANO-HETEROCICLILPENT-2-EN-4-INAS REPLACED AS ACTIVE PRINCIPLES PLANTS ABIOTIC
AR103024A1 (en) 2014-12-18 2017-04-12 Bayer Cropscience Ag SELECTED PYRIDONCARBOXAMIDS OR ITS SALTS AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANTS STRESS
AT518612B1 (en) * 2015-02-06 2019-03-15 Chemiefaser Lenzing Ag Polysaccharide suspension, process for its preparation and its use
BR112017022000A2 (en) 2015-04-13 2018-07-03 Bayer Cropscience Ag n-cycloalkyl-n- (biheterocyclylethylene) - (thio) carboxamide derivatives.
AU2016279062A1 (en) 2015-06-18 2019-03-28 Omar O. Abudayyeh Novel CRISPR enzymes and systems
WO2018019676A1 (en) 2016-07-29 2018-02-01 Bayer Cropscience Aktiengesellschaft Active compound combinations and methods to protect the propagation material of plants
BR112019005660A2 (en) 2016-09-22 2019-06-04 Bayer Cropscience Ag new triazole derivatives and their use as fungicides
BR112019005668A2 (en) 2016-09-22 2019-06-04 Bayer Ag new triazole derivatives
US20190225974A1 (en) 2016-09-23 2019-07-25 BASF Agricultural Solutions Seed US LLC Targeted genome optimization in plants
CA3041351A1 (en) 2016-10-26 2018-05-03 Bayer Cropscience Aktiengesellschaft Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications
EP3550973A1 (en) 2016-12-08 2019-10-16 Bayer CropScience Aktiengesellschaft Use of insecticides for controlling wireworms
EP3332645A1 (en) 2016-12-12 2018-06-13 Bayer Cropscience AG Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress
WO2018108627A1 (en) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants
WO2018204777A2 (en) 2017-05-05 2018-11-08 The Broad Institute, Inc. Methods for identification and modification of lncrna associated with target genotypes and phenotypes
WO2019025153A1 (en) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants
KR20200066616A (en) 2017-09-21 2020-06-10 더 브로드 인스티튜트, 인코퍼레이티드 Systems, methods and compositions for targeted nucleic acid editing
US10968257B2 (en) 2018-04-03 2021-04-06 The Broad Institute, Inc. Target recognition motifs and uses thereof
JP2021525774A (en) 2018-06-04 2021-09-27 バイエル アクチェンゲゼルシャフトBayer Aktiengesellschaft Herbicidal active bicyclic benzoylpyrazole
CA3124110A1 (en) 2018-12-17 2020-06-25 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3442676A (en) * 1965-12-29 1969-05-06 Fmc Corp Method of preparing a stable wax dispersion using beta-1,4 glucan
JPH06287887A (en) * 1993-03-31 1994-10-11 Mitsubishi Paper Mills Ltd Paper containing bacterial cellulose
JP3268057B2 (en) * 1993-04-27 2002-03-25 三菱製紙株式会社 Anti-counterfeit paper

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9747807A1 *

Also Published As

Publication number Publication date
JP2000512348A (en) 2000-09-19
AU6541496A (en) 1998-01-07
AU729286B2 (en) 2001-02-01
CA2257622C (en) 2003-02-11
WO1997047807A1 (en) 1997-12-18
CA2257622A1 (en) 1997-12-18

Similar Documents

Publication Publication Date Title
US5712107A (en) Substitutes for modified starch and latexes in paper manufacture
AU729286B2 (en) Substitutes for modified starch in paper manufacture
AU731253B2 (en) Substitutes for modified starch in paper manufacture
AU731229B2 (en) Substitutes for modified starch in paper manufacture
US6596928B1 (en) Plants synthesizing a modified starch, the generation of the plants, their use, and the modified starch
US6825342B1 (en) Plant starch composition
US7429657B2 (en) DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
US6794558B1 (en) Nucleic acid module coding for αglucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch
US6791010B1 (en) Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications
US6465203B2 (en) Glucan-containing compositions and paper
JP2003507034A (en) Transgenic plant cells and plants with modified GBSSI and BE protein activity
SK15772000A3 (en) Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch
US6127602A (en) Plant cells and plants transformed with streptococcus mutans genes encoding wild-type or mutant glucosyltransferase D enzymes
EP1048730A2 (en) Streptococcus mutans glucosyltransferase B mutants
EP1048729A2 (en) Streptococcus mutans glucosyltransferase D mutants

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981211

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020322

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041119